Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection

Sexual Health

Volumn 6, Issue 3, 2009, Pages 254-257

  Chaubey, Santosh K ^a   Sinha, Ashim K ^a   Phillips, Elizabeth ^b   Russell, Darren B ^a,c   Falhammar, Henrik ^a,d  

^a CAIRNS BASE HOSPITAL   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antiretroviral therapy

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; AMPRENAVIR PHOSPHATE; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EMTRICITABINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; RITONAVIR; TENOFOVIR;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; DIZZINESS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECG ABNORMALITY; EXERCISE ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PACEMAKER; SINUS ARREST; SINUS RHYTHM;

ADULT; ANTI-HIV AGENTS; ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PYRIMIDINONES; RITONAVIR;

EID: 68349087882     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH09005     Document Type: Article

References (11)

1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. November 3, 2008; 1-139. Available online at: http://www.aidsinfo. nih.gov/ContentFiles/AdultandAdolescentGL.pdf. [verifiedDecember 2008].
2. Kikuchi Y, Genka I, Ishizaki A, Sunagawa K, Yasuoka A, Oka S. Serious bradyarrhythmia that was possibly induced by lopinavirritonavir in 2 patients with acquired immunodeficiency syndrome. Clin Infect Dis 2002; 35: 488-490 doi: 10.1086/341975 (Pubitemid 34852580)
3. Yotsumoto M, Kitano K, Saito H. Bradycardia-tachycardia syndrome induced by lopinavir-ritonavir in a patient with AIDS. AIDS 2005; 19: 1547-1548 doi: 10.1097/01.aids.0000183942.05849.1b (Pubitemid 41400703)
4. Jimenez FJ, Pinilla J, Repiso M, Labarga P. Complete autriculoventricular block in a patient treatment with lopinavir/ritonavir. Enferm Infect Microbiol Clin 2002; 20: 418. (Pubitemid 35315351)
5. Busti AJ, Tsikouris JP, Peeters MJ, Das SR, Canham RM, Abdullah SM, et al. A prospective evaluation of the effect of atazanavir on the QTc interval and QTc dispersion in HIV-positive patients. HIV Med 2006; 7: 317-322 doi: 10.1111/j.1468-1293. 2006.00382.x
6. Grody WW, Cheng L, Lewis W. Infection of the heart by the human immunodeficiency virus. Am J Cardiol 1990; 66: 203-206 doi: 10.1016/0002- 9149(90)90589-S (Pubitemid 20235730)
7. Anson BD, Weaver JG, Ackerman MJ, Akinsete O, Henry K, January CT, et al. Blockade of HERG channels by HIV protease inhibitors. Lancet 2005; 365: 682-686 (Pubitemid 40260891)
8. Schulze-Bahr E, Neu A, Friederich P, Kaupp UB, Breithardt G, Pongs O, et al. Pacemaker channel dysfunction in a patient with sinus node disease. J Clin Invest 2003; 111: 1537-1545 (Pubitemid 38063286)
9. Benson DW, Wang DW, Dyment M, Knilans TK, Fish FA, Strieper MJ, et al. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest 2003; 112: 1019-1028 (Pubitemid 38056317)
10. Bezzina CR, Shimizu W, Yang P, Koopmann TT, Tanck MW, Miyamoto Y, et al. Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction. Circulation 2006; 113: 338-344 (Pubitemid 43803194)
11. Shimizu W. Clinical impact of genetic studies in lethal inherited cardiac arrhythmias. Circ J 2008; 72: 1926-1936 doi: 10.1253/circj.CJ-08-0947